Hemostat for treating dysfunctional uterina bleeding and bleeding after putting intrauterine device and its preparing method
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A uterine bleeding and functional technology, applied in the field of preparation of the medicine, can solve the problems of unsuitability for routine application, influence on breastfeeding, side effects of antibiotics and the like
Inactive Publication Date: 2005-04-20
TIANJIN HORUS CANDK PHARMA CO LTD
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, it can produce temporary severe hypertension, water intoxication and other side effects, so it is not suitable for routine use
[0006] 2. Surgical treatments such as curettage and curettage should be used with caution, and there are certain indications
Antibiotics that must be added after surgery have side effects and affect breastfeeding
[0007] 3. At present, there is a lack of Chinese patent medicines for the treatment of this disease, and the only few such as motherwort preparations, modified Shenghua decoction, etc. are not very effective, and cannot meet the needs of clinical medicine.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0045] A hemostatic agent for treating functional uterine bleeding and hemorrhage after circumcision, characterized in that it is made of the following raw materials, and the various raw materials are proportioned by weight:
[0046] 4-15 parts of oysters, 2-10 parts of white peony, 2-10 parts of arborvitae leaves
[0047] 2-10 parts of rehmannia, 2-10 parts of golden cherry seeds, 1-7 parts of Bupleurum
[0048] Panax notoginseng 0.1-5 parts Agrimony 2-10 parts Toon bark 2-10 parts
[0049] Folium Folium 2-10 parts.
Embodiment 2
[0051] The preferred proportioning of each raw material by weight is:
[0052] 3-10 parts of oysters, 3-8 parts of white peony, 3-8 parts of arborvitae leaves
[0053] 3-8 parts of rehmannia, 3-8 parts of golden cherry, 1-5 parts of Bupleurum
[0054] Panax notoginseng 0.1-3 parts Agrimony 3-8 parts Toon bark 3-8 parts
[0055] Folium Folium 3-8 parts.
Embodiment 3
[0057] The further preferred proportioning of each raw material by weight is:
[0058] 6-7 parts of oysters, 3-4 parts of white peony, 4-5 parts of arborvitae leaves
[0059] 3-4 parts of rehmannia, 4-5 parts of golden cherry seeds, 1-2 parts of Bupleurum
[0060] Panax notoginseng 0.1-1 part Agrimony 4-5 parts Toon bark 3-4 parts
[0061] Folium Folium 3-4 parts.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a hemostatic agent for treating functional uterine bleeding and hemorrhage after upper circumcision and a preparation method thereof. Grass, tsubaki bark, and Folium folium are used as raw materials. According to the texture of the medicinal material and the active ingredients of the drug, they are processed by crushing after processing, solvent extraction, etc., and then purified, concentrated, dried, and granulated to make granules. The formula and the preparation method of the invention are unique, and the granulation effect is remarkable.
Description
(1) Technical field [0001] The invention relates to a medicine for treating functional uterine bleeding and hemorrhage after circumcision, specifically a hemostatic agent prepared from Chinese herbal medicine, and also relates to a preparation method of the medicine. (2) Background technology [0002] Menorrhagia and prolonged menstruation are common and frequently-occurring diseases in gynecology. This type of disease has a high incidence rate, and many patients often have recurrent attacks and are lingering and difficult to heal. They are a class of diseases that seriously affect women's physical and mental health, and also bring a lot of inconvenience to patients' work, study and daily life. Some patients can cause other series of gynecological diseases because of the occurrence of the above diseases. [0003] According to the report of the National IUD Research and Cooperation Group: The main side effect after using the metal contraceptive ring is excessive menstruation...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more